Biocompatibility evaluation of breathing gas pathways in healthcare applications - Part 4: Tests for leachables in condensate
1Key Takeaways
This standard specifies the test method for testing extractables from condensed water in the biocompatibility assessment of medical devices in the breathing gas path, with the aim of protecting patients from the potential hazards of these substances.
2Expert Interpretation
This article provides an in-depth interpretation of the ISO 18562-4:2017 standard, focusing on the biocompatibility assessment method for leachables from condensate in the respiratory gas pathways of medical devices. It covers detection techniques for metal ions and organic impurities, cytotoxicity testing requirements, and the principles for developing acceptance criteria based on risk management, providing guidance for respiratory therapy device manufacturers on implementing compliance.
Interpretation of the Standard's Core Content
ISO 18562-4:2017, Part 4 of a series of standards for the biocompatibility assessment of respiratory gas pathways, specifically establishes a testing framework for leachables from condensate during the use of medical devices. This standard applies to equipment that may generate condensate, such as ventilators and anesthesia workstations.
Key Technical Requirements
| Test Items | Detection Method | Acceptance Basis |
|---|---|---|
| Metal Ions | USP<233> or Equivalent Method | USP<232> Limit Requirements |
| Organic Impurities | GC-MS Analysis | Threshold of Toxicological Concern (TTC) |
| Cytotoxicity | ISO 10993-5 | MEM Elution Method Priority |
Test Method Selection Principles
The standard allows for three condensate collection methods: clinical simulated condensation, surface circulation flushing, or ISO 10993-12 water extraction. For special applications such as neonatal respiratory equipment, it is recommended to use the most stringent clinical use conditions for testing.
For example: a nebulizer for short-term use should be tested based on a 20-minute exposure time, while a home ventilator for long-term use should consider a 24-hour cumulative exposure.
Key Points of Risk Assessment
The standard requires the adoption of the ISO 14971 risk management process, focusing on:
- Interaction mechanism between gas path materials and condensate
- The maximum theoretical volume of condensate that patients are exposed to daily is 1ml
- Differences in sensitivity of special populations (such as premature infants)
Implementation Recommendations
1. For nickel-containing components, additional LLNA sensitization testing is required.
2. The inner surface properties of heterogeneous materials (such as coated pipes) should be evaluated separately.
3. It is recommended to establish a material leachate database to support change assessment